"FROM BOOST TO BREAKDOWN "PERFORMANCE ENHANCEMENT AND THE DARK SIDE OF MEPHENTERMINE ADDICTION” A CASE SERIES

Mephentermine, a stimulant used to maintain blood pressure in hypotensive states, is also a drug misused for performance enhancement due to its central nervous system effects1. Here are four cases highlighting its misuse: in which a patient presented with insomnia and irritability experienced palpitation, headaches, hypertension, and depressive symptoms after using mephentermine for a year to boost work performance. Whenever he tried to discontinue or reduce the dose, he developed withdrawal symptoms like fatigue, weakness, agitation, irritability, aggressiveness, etc. In all cases, the misuse aimed at performance enhancement led to signicant physical or psychiatric problems (mental health issues). This study helps to underscore the need for awareness about mephentermine's harmful and addictive effects and the importance of regulating its availability.

Authors

Institutions

Publication Details

Journal
GLOBAL JOURNAL FOR RESEARCH ANALYSIS
Published
2024-12-15
DOI
https://doi.org/10.36106/gjra/0506138
Primary Topic
Attention Deficit Hyperactivity Disorder
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

"FROM BOOST TO BREAKDOWN "PERFORMANCE ENHANCEMENT AND THE DARK SIDE OF MEPHENTERMINE ADDICTION” A CASE SERIES

S. K. Chaturvedi, Richa Gupta, Anjesh Mittal, Ajay Pratap Singh
GLOBAL JOURNAL FOR RESEARCH ANALYSIS
Attention Deficit Hyperactivity Disorder
article

"FROM BOOST TO BREAKDOWN "PERFORMANCE ENHANCEMENT AND THE DARK SIDE OF MEPHENTERMINE ADDICTION” A CASE SERIES

S. K. Chaturvedi, Richa Gupta, Anjesh Mittal, Ajay Pratap Singh
article en

Abstract

Mephentermine, a stimulant used to maintain blood pressure in hypotensive states, is also a drug misused for performance enhancement due to its central nervous system effects1. Here are four cases highlighting its misuse: in which a patient presented with insomnia and irritability experienced palpitation, headaches, hypertension, and depressive symptoms after using mephentermine for a year to boost work performance. Whenever he tried to discontinue or reduce the dose, he developed withdrawal symptoms like fatigue, weakness, agitation, irritability, aggressiveness, etc. In all cases, the misuse aimed at performance enhancement led to signicant physical or psychiatric problems (mental health issues). This study helps to underscore the need for awareness about mephentermine's harmful and addictive effects and the importance of regulating its availability.

GLOBAL JOURNAL FOR RESEARCH ANALYSIS
Sarojini Naidu Medical College (IN)
Good health and well-being
Openalex Percentile: Top 66%
Attention Deficit Hyperactivity Disorder
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

"FROM BOOST TO BREAKDOWN "PERFORMANCE ENHANCEMENT AND THE DARK SIDE OF MEPHENTERMINE ADDICTION” A CASE SERIES — S. K. Chaturvedi, Richa Gupta, et al. · GLOBAL JOURNAL FOR RESEARCH ANALYSIS (2024) | TGRS Research Map | TGRS